Want to see SG:V8Y full AI Analyst Report?
Quantum Healthcare Ltd. (V8Y) AI Stock Analysis
Top Page
Quantum Healthcare Ltd.
(SGX:V8Y)
The score is primarily weighed down by weak profitability and a fragile balance sheet with persistent negative equity, despite improving revenue momentum and recently positive operating/free cash flow. Limited valuation support (negative P/E due to losses) and unavailable technical signals keep the overall assessment cautious.
Quantum Healthcare Ltd. Business Overview & Revenue Model
Company Description
Quantum Healthcare Limited, a Singapore-based enterprise established in 2005, specializes in the design, assembly, and commercialization of sophisticated therapeutic solutions for the minimally invasive management of intricate vascular diseases. The...
Quantum Healthcare Ltd. Financial Statement Overview
Summary
Revenue growth is strong (TTM +18.2%) with stable mid-40% gross margins, and TTM operating/free cash flow are positive. However, operating and net margins remain meaningfully negative (about -21% net margin) and stockholders’ equity is negative across periods, creating elevated financing and balance-sheet risk.
Income Statement
34NegativeBalance Sheet
22NegativeCash Flow
56Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.21M | 13.06M | 12.69M | 13.08M | 9.37M | 0 |
| Gross Profit | 5.94M | 5.93M | 5.66M | 5.76M | 4.35M | -246.00K |
| EBITDA | -841.00K | -686.00K | -318.00K | -1.45M | -7.23M | -5.09M |
| Net Income | -2.76M | -2.74M | -2.23M | -3.62M | -9.07M | -5.28M |
Balance Sheet | ||||||
| Total Assets | 10.42M | 10.79M | 12.53M | 13.03M | 14.45M | 916.00K |
| Cash, Cash Equivalents and Short-Term Investments | 1.56M | 2.59M | 386.00K | 744.00K | 5.07M | 344.00K |
| Total Debt | 3.87M | 4.18M | 7.64M | 6.51M | 7.55M | 997.00K |
| Total Liabilities | 11.72M | 11.85M | 15.50M | 16.06M | 15.35M | 3.55M |
| Stockholders Equity | -1.83M | -1.52M | -3.62M | -3.87M | -1.50M | -2.59M |
Cash Flow | ||||||
| Free Cash Flow | 941.00K | 1.89M | 1.09M | -926.00K | -2.23M | -964.23K |
| Operating Cash Flow | 999.00K | 1.94M | 1.45M | -628.00K | -1.30M | -964.23K |
| Investing Cash Flow | -46.00K | -38.00K | -1.07M | -3.42M | -5.04M | 59.89K |
| Financing Cash Flow | 412.00K | 419.00K | -733.00K | -272.00K | 11.06M | 177.47K |
Quantum Healthcare Ltd. Peers Comparison
Overall Rating
SG:BSL66Neutral
SG:A5048Neutral- SG:V8Y42Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| SG:BSL | 66Neutral | SGD 1.55B | 22.40 | 6.42% | 3.66% | -3.18% | 6.71% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| SG:A50 | 48Neutral | SGD 1.27B | -41.13 | -6.42% | ― | 6.44% | 38.89% |
| SG:V8Y | 42Neutral | SGD 12.59M | -3.33 | 118.31% | ― | 2.08% | -50.00% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| SG:BSL | Raffles Medical Group | 0.82 | -0.14 | -14.58% | |
| SG:A50 | Thomson Medical Group Ltd. | 0.05 | -0.01 | -20.00% | |
| SG:1D4 | Aoxin Q&M Dental Group Ltd. | 0.16 | 0.12 | 336.11% | |
| SG:40T | ISEC Healthcare Ltd | 0.31 | -0.02 | -6.91% | |
| SG:505 | Asiamedic Limited | 0.02 | -0.00 | -19.05% |
Quantum Healthcare Ltd. Corporate Events
Quantum Healthcare reallocates placement funds and issues secured S$600,000 promissory note
Quantum Healthcare has updated investors on the use of S$3 million raised through a placement of over 2.7 billion new shares, indicating that S$855,000 has been spent on working capital such as directors’ fees, salaries, professional and admini...
Quantum Healthcare AGM backs board, renews capital and buy-back mandates
Quantum Healthcare Ltd. reported that all resolutions at its fourth annual general meeting were passed by poll with unanimous support from shareholders present or by proxy. Shareholders adopted the audited financial statements for the year ended 31 D...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 19, 2026